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ThObjective: To (1) characterize atrial fibrillation complicating lung cancer resection,
(2) evaluate its temporal relationship to other postoperative complications, and (3)
assess its economics.
Methods: From January 1998 to August 2002, 604 patients underwent anatomic
lung cancer resection. Atrial fibrillation prevalence, onset, and temporal associations
with other postoperative complications were determined. Propensity matching was
used to assess economics.
Results: Atrial fibrillation occurred in 113 patients (19%), peaking on postoperative
day 2. Older age, male gender, heart failure, clamshell incision, and right pneumo-
nectomy were risk factors (P  .01). Although atrial fibrillation was solitary in 75
patients (66%), other postoperative complications occurred in 38. Respiratory and
infectious complications were temporally linked with atrial fibrillation onset. In 91
propensity-matched pairs, patients developing atrial fibrillation had more other
postoperative complications (30% vs. 9%, P  .0004), had longer postoperative
stays (median 8 vs 5 days, P  .0001), incurred higher costs (cost ratio 1.8, 68%
confidence limits 1.6-2.1), and had higher in-hospital mortality (8% vs 0%, P 
.01). Even when atrial fibrillation was a solitary complication, hospital stay was
longer (median 7 vs 5 days, P  .0001), and cost was higher (cost ratio 1.5, 68%
confidence limits 1.2-1.6).
Conclusion: Atrial fibrillation occurs in 1 in 5 patients after lung cancer resection,
with peak onset on postoperative day 2. Risk factors are both patient and procedure
related, and atrial fibrillation may herald other serious complications. Although
often solitary, atrial fibrillation is associated with longer hospital stay and higher
cost. It therefore requires prompt treatment and should stimulate investigation for
other problems.
Atrial fibrillation (AF) commonly complicates pulmonary resection.1-14 Al-though AF is medically manageable, its impact on recovery and economics isunclear.6-8,15 We hypothesized that it might herald poor outcome, and we
therefore (1) characterized AF complicating lung cancer resection, (2) evaluated its
temporal relation to other postoperative complications, and (3) assessed its
economics.
Patients and Methods
Patients
Between January 1998 and August 2002, 625 consecutive patients undergoing anatomic
resection for non–small cell lung cancer at The Cleveland Clinic Foundation were identified
from the Thoracic Surgery Database. Of these, 21 were excluded because they had permanent
AF (n  13), previous lung transplantation (n  1), previous lung resection (n  4), or
incomplete records (n  3).15 Patients who had a history of paroxysmal AF but were in sinus
rhythm at operation were included. Thus, 604 patients were studied (Table 1). The Thoracic
Surgery Database has been approved for use in research by the institutional review board.
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Resection was universally completed extrapericardially, with in-
trapericardial resection rescored for those cases listed as such
(Table E1). All preoperative medications were resumed when
enteral feedings were begun (usually postoperative day 1). No
attempt was made to provide prophylaxis against the development
of AF.
Postoperative AF
All patients had heart rhythm telemetry throughout their hospital
TABLE 1. Patient and operative characteristics
Variable Total (n  604)
Demographic
Male (No.) 352 (58%)
Age (y, mean  SD) 64  11
Cardiovascular comorbidity (No.)
History of paroxysmal AF 32 (5%)
History of ventricular arrhythmia 5/597 (1%)†
Coronary artery disease 112/548 (19%)
Mitral valve disease 14/547 (2%)
Heart failure 22/547 (4%)
History of pulmonary embolism 4/597 (1%)
Hypertension 93/547 (16%)
Previous cardiac operation 56 (9%)
Noncardiac comorbidity (No.)
Smoking 521/536 (97%)
Previous thoracotomy 2 (0.3%)
Hyperthyroidism 1/597 (0.2%)
ECOG score
0 287 (48%)
1 243 (41%)
2 63 (10.5%)
3 3 (0.5%)
Not recorded 8
Procedure (No.)
Approach
Thoracotomy 596 (99%)
Clamshell incision 4 (0.7%)
Sternotomy 4 (0.7%)
Anatomic resection
Pneumonectomy 85 (14%)
Right 37 (6%)
Left 48 (8%)
Intrapericardial 15 (2%)
Lobectomy 474 (78%)
Segmentectomy 48 (8%)
Additional procedures (No.)
Wedge resection 44 (7%)
Sleeve resection 20 (3%)
Mediastinal lymph node dissection 310 (51%)
Chest wall resection 28 (5%)
AF, Atrial fibrillation; ECOG, Eastern Cooperative Oncology Group; SD, stand
test used where appropriate. †Denominator represents number of patientstay. Postoperative AF was defined as electrocardiographically
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lated from time of incision.
Other Postoperative Complications
Other hospital complications were categorized as respiratory, in-
fectious, pleural, renal, and other cardiovascular (Appendix 1).
Interval for each was calculated from onset of AF; complications
were then categorized as preceding onset of AF (between incision
and 12 hours before onset of AF), coincident with AF (within 12
hours before or after), or after onset of AF (more than 12 hours
Postoperative AF
P value*Yes (n  113) No (n  491)
85 (75%) 267 (54%) .0001
68  8.0 63 12 .0001
18 (16%) 14 (3%) .0001
2/112 (2%) 3/485 (0.6%) .2
37/112 (33%) 75/486 (15%) .0001
5/112 (4%) 9/485 (2%) .15
13/112 (12%) 9/485 (2%) .0001
2/112 (2%) 2/485 (0.4%) .16
32/112 (28%) 61/485 (13%) .0001
17 (15%) 39 (8%) .02
103/107 (96%) 418/429 (97%) .5
2 (2%) 0 (0%) .03
0/112 (0%) 1/485 (0.2%) 1.0
.08
44 (39%) 243 (50%)
52 (46%) 191 (39%)
17 (15%) 46 (9%)
0 (0%) 3 (1%)
0 8
110 (97%) 486 (99%) 1.0
3 (3%) 1 (0.2%) .02
0 (0%) 4 (0.8%) 1.0
24 (21%) 61 (12%) .01
15 (13%) 22 (4%) .0004
9 (8%) 39 (8%) .99
4 (4%) 11 (2%) .5
81 (72%) 393 (80%) .05
9 (8%) 39 (8%)‡ .99
5 (4%) 39 (8%) .2
6 (5%) 14 (3%) .2
55 (49%) 255 (52%) .5
4 (4%) 24 (5%) .5
viation. *Test of difference between AF and non-AF groups; Fisher’s exact
out missing data. ‡One patient had lobectomy and segmentectomy.ard deafter AF).
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Economics of AF were assessed by (1) prevalence of other post-
operative complications, (2) postoperative length of stay, (3) post-
operative direct technical costs exclusive of operative day, and
(4) in-hospital mortality. Direct technical costs include those di-
rectly associated with patient care, obtained from the hospital’s
meticulously detailed cost-accounting system: room, intensive care
unit, nursing, pharmacy, respiratory therapy, radiology, laboratory,
pain management, and miscellaneous (for details, see http://www.
eclipsys.com/Solutions/executives.asp). Indirect costs and profes-
sional fees were not included.
Data Analysis
Characterization of postoperative AF. Prevalence of, timing
Figure 1. AF complicating lung cancer resection. A, Hazard (in-
stantaneous risk). Solid line is parametric estimate enclosed
within dashed 68% confidence limits. B, Freedom from AF. Each
circle represents onset of AF; vertical bars are asymmetric 68%
CLs, and numbers in parentheses are patients remaining at risk.
Solid line is parametric estimate enclosed within dashed 68%
CLs.of, and risk factors for postoperative AF were characterized in the
The Journal of Thoracic ahazard function domain.16 Variables examined are listed in Ap-
pendix 2. Variable selection was based on bootstrap bagging with
a retention criterion of P  .05.17,18
Temporal relation to other postoperative complications. For
each other postoperative complication, the relation of its onset to
that of AF was determined and is presented as a cumulative
distribution.
Economics. To make a fair comparison of the impact of AF on
outcome, a propensity score was developed to match patients with
AF to those without.19,20 Ninety-one patient pairs were produced
(Table E1). Outcome measures were compared between the two
groups with the Wilcoxon rank-sum test for simple proportions
(other postoperative complications and mortality), median test
(postoperative length of stay), and ratio test (direct technical costs
from postoperative day 1 to discharge). For the last, the cost ratio
(AF group/non-AF group) of each matched pair was calculated.
Confidence limits (CL) were determined from the distribution of
median ratio in 10,000 bootstrap resamplings. These comparisons
were repeated for the subgroup of patients with AF but without
other postoperative complications and with matched pairs.
Presentation. Mean values are accompanied by 1 SD and
regression coefficients by 1 SE. Proportions and other point esti-
mates are accompanied by asymmetric CLs equivalent to 1 SE
(68%). We have avoided presenting logistic regression results as
odds ratios because of data transformations.
Results
Characterization of AF
AF occurred in 113 patients (19%, CL 17%-20%). Patient
characteristics and operative details of this group versus
those without AF are given in Table 1. Risk of AF peaked
on day 2 (Figure 1, A); patients free of AF by postoperative
day 5 seldom developed it (Figure 1, B).
Risk factors for AF included older age, male gender,
paroxysmal AF, heart failure, clamshell incision, and right
pneumonectomy (Table 2). Histories of paroxysmal AF and
heart failure were associated with importantly increased
occurrence of postoperative AF, particularly in older pa-
TABLE 2. Risk factors for postoperative AF
Factor Logistic coefficient  SE P value
Demographic
Older* 3.4 0.82 .0001
Male 0.65 0.25 .009
Comorbidities
Paroxysmal AF 1.4 0.40 .0004
Heart failure 1.3 0.49 .006
Procedure
Clamshell incision 3.5 1.3 .007
Right pneumonectomy 1.7 0.39 .0001
Intercept 16.4 3.5 .0001
c-statistic  0.74. AF, Atrial fibrillation; SE, standard error. *Logarithmic
transformation.tients (Table 2, Figure 2). Right pneumonectomy also was
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(Figure 2, B).
Temporal Relation to Other Postoperative
Complications
Among the 113 patients who had postoperative AF, it was
a solitary complication in 75 (66%, CL 61%-71%). Thirty-
eight (33%, CL 29%-39%) had other postoperative compli-
cations, including respiratory in 30 patients, infectious in
21, pleural in 14, renal in 5, and other cardiovascular in 14
(some patients had multiple complications). AF preceded
these other complications in 14 patients (37%, CL 28%-
46%), coincided within 24 hours in 11 (29%, CL 21%-
38%), and followed in 13 (34%, CL 26%-43%; Figure 3).
Only 13% (CL 7%-22%) of respiratory complications
Figure 2. Risk factors for postoperative AF based on multivariable
analysis (Table 2). A, Association with paroxysmal AF, heart
failure, and age solved for man undergoing thoracotomy for
lobectomy. Plus and minus signs indicate presence and absence
of one of the two risk factors. B, Association with right pneumo-
nectomy solved for man without paroxysmal AF or heart failure
undergoing thoracotomy. Dashed lines represent 68% CLs.preceded AF, whereas 37% (CL 27%-47%) coincided, and
438.e4 The Journal of Thoracic and Cardiovascular Surgery ● A50% (CL 39%-60%) followed (Figure E1, A). All infectious
complications occurred either coincident with or after onset
of AF, and, similar to respiratory complications, most oc-
curred within 1 week of AF onset (Figure E1, B). Unlike
these, half the pleural complications preceded onset of AF
and appeared unrelated (Figure E1, C); many of these were
postoperative hemothorax occurring within 24 hours of
operation, much earlier than peak onset of AF. Renal failure
occurred in 4 patients in the setting of multisystem organ
failure and sepsis, all after onset of AF. Sixty-four percent
(CL 47%-79%) of other cardiovascular complications fol-
lowed onset of AF (Figure E1, D).
Economics
Other postoperative complications occurred in a greater
proportion of propensity-matched patients who developed
AF than in patients who did not (30% vs 8.8%, P  .0004;
Table 3). Postoperative hospital stay was longer for patients
developing postoperative AF than for those who did not
(median 8 days, 15th and 85th percentiles 5 and 14 days, vs
5 days, 15th and 85th percentiles 4 and 10 days; P .0001),
and direct technical costs of postoperative care were higher
(cost ratio 1.8, CL 1.6-2.1). In-hospital mortality was also
higher at 8% (7/91, CL 5%-11%) versus 0% (0/91, CL
0%-1.2%; P  .01).
Sixty-four of the 75 patients in whom AF was a solitary
complication could be propensity matched. Postoperative
hospital stay was longer for these patients than for their
matched counterparts who did not develop AF (median 7
days, CL 5-9 days, vs 5 days, CL 4-8 days; P  .0001), and
direct technical costs of postoperative care were higher (cost
Figure 3. Temporal relation of other postoperative complications
to onset (time 0) of postoperative AF. Cumulative distribution
curve. Area between dashed lines represents coincidence of
complications.ratio 1.5, CL 1.2-1.6).
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Because postoperative AF is readily managed, its impor-
tance is often unappreciated.6-8 Yet, apart from air leak,21
no single postoperative complication occurs as frequently:
Every fifth patient in this study had it.
Characterization of AF
Without prophylaxis,14 prevalence of AF after pulmonary
resection has ranged from 8% to 42%,1-13 and, as in this
study, peak onset is on the second postoperative day.4-8
However, differences in composition of the patient groups
make comparisons among studies difficult. This is because,
as expected from studies in the general population,22 older
patients, men, and those with a history of previous arrhyth-
mias and underlying heart disease have a high prevalence of
postoperative AF.1,23 To these are added risk factors par-
ticular to pulmonary resection, including open versus video-
assisted thoracic surgery,13 clamshell versus thoracotomy
(in this study), and pneumonectomy versus lobec-
tomy.4-6,8,11,12 Differences in prevalence of these powerful
risk factors among operative experiences greatly affect oc-
currence of AF.4-6,8,12
Temporal Relation to Other Postoperative
Complications
In two thirds of the patients, AF was a solitary complication.
TABLE 3. Other postoperative complications in propensity
Complication (No.) Postoperative AF
Respiratory 23 (25%)
Respiratory distress 16
Respiratory failure 15
Pneumonia 12
Bronchopleural fistula 1
Infectious 14 (15%)
Sepsis 9
Pneumonia 12
Wound infection 1
Empyema 1
Pleural 11 (12%)
Pneumothorax 3
Hemothorax 7
Pleural effusion 2
Empyema 1
Bronchopleural fistula 1
Renal failure 4 (4.4%)
Other cardiovascular 12 (13%)
Myocardial infarction 2
Ventricular arrhythmia 5
Arterial thrombosis 2
Deep vein thrombosis 5
Pulmonary embolism 1
Any complication 27 (30%)
AF, Atrial fibrillation. *Complications are not mutually exclusive.In the other third, however, other complications occurred,
The Journal of Thoracic aand this study uniquely identified their temporal relation to
onset of AF. There was a particularly close temporal link
with respiratory and infectious complications. Processes
such as sepsis and hypoxia can stimulate inflammatory and
autonomic responses that may trigger AF in these vulnera-
ble patients.24,25 Thus, AF may reflect the early systemic
manifestations of these serious complications.
Economics
According to our propensity-matched study, postoperative
AF is a marker for a complicated, prolonged, expensive, and
possibly lethal postoperative course. Because of the impos-
sibility of a prospective study, inferences concerning the
economic importance of AF vary widely.3,6-9,11,14 Recently,
Vaporciyan and colleagues1 reported that postoperative
AF in a large, uncontrolled experience of thoracic sur-
gery was associated with increased length of stay, cost,
and mortality. Propensity matching in our study permit-
ted more controlled comparisons that support their find-
ings. In addition, other complications and death occurred
more often among patients who had postoperative AF.
This is similar to the findings of Murthy and colleagues,26
who noted that patients with postoperative AF had more
pulmonary and septic complications and higher mortality
after esophagectomy than propensity-matched patients
ched patient pairs (91 pairs)
No postoperative AF P value
5 (5.5%) .0002
5
2
1
0
2 (2.2%) .002
1
1
1
0
2 (2.2%) .01
1
0
1
0
0
0 (0%) .12
1 (1.1%) .002
1
1
1
0
0
8 (8.8%) .0004-matwithout AF.
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was a solitary postoperative complication, length of stay, costs,
and in-hospital mortality were considerably higher. This was
due to the costs of managing the AF, highlighting the need for
effective prophylaxis and improved management of AF.
Strengths and Limitations
A strength of this study is that it addressed a defined problem
(postoperative AF monitored continuously throughout the hos-
pital course) in a large group of patients with a single disease
(non–small cell lung cancer) undergoing a single type of
operation (anatomic resection) in the contemporary era.
Another is the novel approach we have taken to generate
valid conclusions. We have identified on a continuous time
line the clinical onset of early postoperative complications,
expressing these in relation to onset of AF; we have used
meticulous cost-accounting data, not charges; and we have
used propensity matching, which is considered to be the
most valid method for making comparisons in the context of
nonrandomized (in this case, nonrandomizable) studies of
clinical experience.
A limitation is that it was a single-institution clinical
cohort study, which restricts its generalizability. Although
most patients (81%) were matched, propensity methods of
comparison are limited by inability to account for unre-
corded variables. Unmatched patients included those with
clamshell incisions who had complex operations that usu-
ally required chest wall or central airway resection. Because
we monitored AF continuously, the period of study ex-
tended only to hospital discharge. Finally, from this clinical
study it is impossible to determine the biologic mechanisms
responsible for the observed associations.
Recommendations
Because postoperative AF is a solitary complication in about
two thirds of the patients in whom it occurs, treatments di-
rected at rate control and rhythm conversion are initially most
important.5,15,27 These include correcting electrolyte abnor-
malities, intravenous calcium-channel blockers or -blockers,
and pharmacologic or electrical cardioversion for patients with
recurrent or refractory AF.5,15,27 Because in another third of
patients it is associated with more serious complications, how-
ever, occurrence of AF should trigger a thorough workup,
including physical examination, chest radiography, pulse
oximetry, and white blood cell count.
Conclusions
AF occurs in 1 in 5 patients after lung cancer resection, with
peak onset on postoperative day 2. Risk factors are both
patient and procedure related, and AF may herald other
serious complications. Although AF is often solitary, its
occurrence is associated with longer hospital stay and
438.e6 The Journal of Thoracic and Cardiovascular Surgery ● Ahigher cost. It therefore requires prompt treatment and
should stimulate investigation for other problems.
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Appendix 1: Modes of confirmation of other
complications
Respiratory
Respiratory distress. Increasing oxygen requirements necessi-
tating transfer to the intensive care unit.
Respiratory failure. Mechanical ventilation after reintubation
or tracheostomy.
Pneumonia.28 (1) Rales or dullness to percussion on physical
examination; (2) chest radiograph showing new infiltrate, consol-
idation, cavitation, or effusion; and (3) any one of the following:
(a) purulent sputum, (b) isolation of organism from blood culture,
or (c) isolation of pathogen from tracheal aspirate or bronchial
washing.
Bronchopleural fistula. Confirmed at operation.
Infectious
All infectious diagnoses were confirmed by a staff consultant
from the Department of Infectious Disease.
Sepsis.29 Presence of organ dysfunction with two or more of
the following features of infection-induced systemic inflammation:
(1) fever or hypothermia, (2) tachycardia, (3) tachypnea, (4) leu-
kocytosis or leukopenia.The Journal of Thoracic aPneumonia. As defined for respiratory category.
Wound infection. Drainage or cellulitis for which the wound is
opened.
Empyema. Purulent chest tube drainage or thoracentesis con-
firmed by culture.
Pleural
Pneumothorax, hemothorax, pleural effusion. Diagnosed by
chest radiography and requiring tube thoracostomy or operative
drainage.
Empyema and bronchopleural fistula. As defined for infec-
tious and respiratory categories.
Renal
Renal failure. Need for dialysis.
Other Cardiovascular
Myocardial infarction.30 Rise and fall of creatine kinase isoen-
zyme MB or troponin with at least one of the following: (1) symp-
toms, (2) Q waves on electrocardiogram, (3) electrocardiographic
changes indicative of ischemia, or (4) coronary intervention.
Ventricular arrhythmias. Documented electrocardiographi-
cally, confirmed by cardiologist, and treated.
Arterial thromboembolism. Clinical scenario of ischemia re-
quiring surgery with confirmation of thromboses at operation.
Deep venous thrombus. Diagnosed by duplex ultrasonography.
Pulmonary embolism. Diagnosed by computed tomography or
pulmonary angiography.
Appendix 2: Variables used in analyses
Demographic. Gender, age (years).
Cardiac comorbidity. Paroxysmal AF, ventricular arrhythmia,
coronary artery disease, previous myocardial infarction, percuta-
neous coronary intervention, atrial septal defect, mitral valve dis-
ease, heart failure, pulmonary embolism, hypertension, previous
cardiac operation.
Noncardiac comorbidity. Smoking (including current, ever,
quit, pack-years), previous thoracotomy, hyperthyroidism, diabe-
tes, Eastern Cooperative Oncology Group score, American Society
of Anesthesiology score.
Procedural. Bronchoscopy and mediastinoscopy before oper-
ation, approach (thoracotomy, clamshell incision, sternotomy),
converted video-assisted thoracic surgery, pneumonectomy (and
anatomic location), lobectomy (and anatomic location), segmen-
tectomy (and anatomic location), wedge (and location), sleeve
resection, mediastinal lymph node dissection, chest wall resection,
surgeon.
Experience. Date of operation (interval in years since January
1998).nd Cardiovascular Surgery ● Volume 130, Number 2 438.e7
General Thoracic Surgery Roselli et alFigure E1. Temporal relation of other postoperative complications to onset (time 0) of postoperative AF. Cumulative
distribution curves. Area between dashed lines represents coincidence of complications. A, Respiratory. B,
Infectious. C, Pleural. D, Other cardiovascular.438.e8 The Journal of Thoracic and Cardiovascular Surgery ● August 2005
Roselli et al General Thoracic SurgeryTABLE E1. Characteristics of propensity-matched patients (n  91 for both groups)
Variable Postoperative AF No postoperative AF P value*
Demographic
Male (No.) 66 (73%) 72 (79%) .3
Age (y, mean  SD) 67  8 66 10 .4
Cardiovascular comorbidity (No.)
History of AF 7 (8%) 8 (9%) .8
History of ventricular arrhythmia 0/90 (0%)† 1/89 (1%) .5
Coronary artery disease 22/90 (24%) 25/90 (28%) .6
Mitral valve disease 4/90 (4%) 4/89 (4%) 1.0
Heart failure 3/90 (3%) 5/89 (6%) .5
History of pulmonary embolism 0/90 (0%) 0/89 (0%) —
Hypertension 17/90 (19%) 21/89 (24%) .4
Previous cardiac operation 11 (12%) 11 (12%) 1.0
Noncardiac comorbidity (No.)
Smoking 83/85 (96%) 85/88 (96%) 1.0
Previous thoracotomy 2 (2%) 0 (0%) .5
Hyperthyroidism 0/90 (0%) 0/89 (0%) —
ECOG score .9
0 39 (43%) 36 (40%)
1 42 (46%) 45 (49%)
2 10 (11%) 10 (11%)
Procedure (No.)
Approach
Thoracotomy 90 (99%) 90 (99%) 1.0
Sternotomy 0 (0%) 0 (0%)
Clamshell incision 1 (1%) 1 (1%) 1.0
Anatomic resection
Pneumonectomy 20 (22%) 16 (18%) .5
Right 11 (12%) 10 (11%) .8
Left 9 (10%) 6 (7%) .4
Intrapericardial 2 (2%) 1 (1%) 1.0
Lobectomy 64 (70%) 69 (76%) .4
Segmentectomy 8 (9%) 6 (7%) .6
Additional procedures (No.)
Wedge resection 5 (5%) 4 (4%) 1.0
Sleeve resection 3 (3%) 4 (4%) 1.0
Mediastinal lymph node dissection 45 (49%) 42 (46%) .7
Chest wall resection 3 (3%) 5 (5%) .7
AF, Atrial fibrillation; ECOG, Eastern Cooperative Oncology Group; SD, standard deviation. *Test of difference between AF and no-AF groups, Fisher’s exact
test used where appropriate. †Denominator represents number of patients without missing data.The Journal of Thoracic and Cardiovascular Surgery ● Volume 130, Number 2 438.e9
